Home > Insider Trading > Filing (0001209191-14-074306)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1069899	Phibro Animal Health Corp	PAHC	Pharmaceutical Preparations (2834)	131840497

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1363803	L.p. Mayflower	22 Grenville Street St. Helier Y9 JE4 8PX		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-04-14	20,610,000	$0.00	0	No	4	J	Indirect	See Footnote
Class A Common Stock	Acquisiton	2014-04-14	9,109,620	$0.00	9,109,620	No	4	J	Indirect	See Footnote
Class A Common Stock	Disposition	2014-04-16	6,323,867	$13.99	2,785,753	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

Pursuant to the Amended and Restated Certificate of Incorporation of the Issuer filed with the Secretary of State of Delaware on April 14, 2014, each share of Common Stock was reclassified as and converted into 0.442 shares of a single class of Class A Common Stock, resulting in an exempt disposition to the Issuer pursuant to Rule 16b-3(e) and Rule 16b-7(a)(2), and a corresponding exempt acquisition from the Issuer pursuant to Rule 16b-3(d) and Rule 16b-7(a)(1), in each case, as promulgated under the Securities Exchange Act of 1934.
Shares are directly held by Mayflower LP ("Mayflower"). Investment and divestment decisions with respect to the shares held by Mayflower are made by the investment committee of 3i Investments plc, which is the manager of Mayflower. 3i Investments plc is an indirect wholly owned subsidiary of 3i Group plc, a public company listed on the London Stock Exchange. 3i Investments plc is advised by 3i Corporation, which is also an indirect wholly owned subsidiary of 3i Group plc.